Streetbeat News

Regulatory

ELAN

Elanco Animal Health's shares are trading higher following the announcement that the Environmental Protection Agency (EPA) has completed its review of the Seresto collar and confirmed its continued registration.

Portfolio Pulse from Benzinga Newsdesk

July 14, 2023 | 12:12 pm

GILD

Gilead Sciences has announced that the FDA has approved a supplemental new drug application for the use of Veklury in COVID-19 patients with severe renal impairment, including those on dialysis.

Portfolio Pulse from Benzinga Newsdesk

July 14, 2023 | 12:04 pm

SPRC

SciSparc Ltd. (NASDAQ:SPRC) has received approval from the Israeli Medical Cannabis Agency to conduct a clinical trial for SCI-210, a proprietary combination of cannabidiol and CannAmide™, in children with autism spectrum disorder. The company has secured all necessary approvals to commence the trial in Israel and aims to sell SCI-210 first in Israel and then globally, subject to regulatory approvals.

Portfolio Pulse from Benzinga Newsdesk

July 14, 2023 | 11:56 am

DOGEUSD

XRPUSD

Dogecoin co-founder Billy Markus commented on the recent court ruling favoring Ripple Labs, stating that XRP is not a security. This decision is a significant turning point in the legal battle between Ripple and the SEC. The SEC has identified 19 other cryptocurrencies as securities in lawsuits against platforms like Binance and Coinbase. At the time of writing, DOGE was trading at $0.070, up 9% in the last 24 hours.

Portfolio Pulse from Mehab Qureshi

July 14, 2023 | 11:53 am

ATVI

MSFT

Microsoft Corp (MSFT) and Activision Blizzard, Inc (ATVI) are reportedly considering giving up some control of their cloud-gaming business in the U.K. to appease regulators and complete their $69 billion merger by July 18. This could involve selling off the cloud-based market rights for games in the U.K. Both companies believe the deal can be closed before the deadline, despite opposition from U.S. and U.K. regulators fearing anticompetitive repercussions.

Portfolio Pulse from Anusuya Lahiri

July 14, 2023 | 11:41 am

ZLAB

Zai Lab has announced the treatment of the first patient in Mainland China as part of its global Phase 3 FORTITUDE-101 study of Bemarituzumab in first-line gastric cancer.

Portfolio Pulse from Benzinga Newsdesk

July 14, 2023 | 11:36 am

DIS

Florida Governor Ron DeSantis is set to participate in his first Republican primary debate on Aug. 23. His performance could significantly impact his standing in the race. DeSantis's campaign has faced several challenges, including criticism from Donald Trump and an ongoing feud with The Walt Disney Company (NYSE:DIS) over the 'Don't Say Gay' bill.

Portfolio Pulse from Benzinga Neuro

July 14, 2023 | 11:22 am

SLM

SOFI

SPY

The Biden administration has forgiven $39 billion in student debt for over 800,000 borrowers. This move could impact the revenues of student loan companies like SLM Corp and SoFi Technologies.

Portfolio Pulse from Charles Gross

July 14, 2023 | 11:07 am

FXI

China's cabinet is reportedly encouraging and attracting more private capital to participate in the construction, renovation, operation, and maintenance of some infrastructure facilities, according to Reuters.

Portfolio Pulse from Charles Gross

July 14, 2023 | 10:45 am

CGC

Canopy Growth Corporation (CGC) has been notified by the Nasdaq that it is not in compliance with Listing Rule 5450(A)(1) due to its common shares closing bid price being below $1.00 per share for 30 consecutive business days.

Portfolio Pulse from Charles Gross

July 14, 2023 | 10:35 am